Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomecompanyPhenylbutazone 50-33-9 98%
Phenylbutazone
Phenylbutazone
Phenylbutazone

Phenylbutazone 50-33-9 98%

Price Get Latest Price
Packge 1MT1kg5kg10kg25kg
  • Min. Order:1MT
  • Time:2024-02-09

Product Details

  • Product NamePhenylbutazone
  • CAS No.50-33-9
  • EINECS No.200-029-0
  • MFC19H20N2O2
  • MW308.37
  • InChIKeyVYMDGNCVAMGZFE-UHFFFAOYSA-N
  • AppearancePowderWhite to almost white
  • Water Solubility <0.1 g/100 mL at 23.5 ºC
  • Melting point 106-108 °C (lit.)
  • storage temp. 2-8°C
  • Boiling point 448.76°C (rough estimate)
  • density 1.1591 (rough estimate)

Company Profile Introduction

Established in 1993 as a small chemical manufacturing firm in Ankleshwar, Reine is now one of the leading manufacturers of select APIs. Our global performance is being multiplied by our leadership excellence and teamwork of our employees.

From select APIs & its advance intermediates, we are manufacturing our products with facilities spread in more than 20,000 sq. mt. area. Facilities at our existing unit comprises of production facilities, product development facilities, R&D, QC-QA Lab, technology transfer & administration building.

We are an Indian pharmaceutical company which believes that everyone has a right to affordable quality medicines.
We have a clear goal of giving patients access to quality and affordable products. For this we are aiming to alter the healthcare paradigm. We are now at strong position to research and develop quality API by optimising cost-effective paths of pharmaceutical chemistry – which is our first step to achieve our goals of patient centricity through optimised chemistry.

Recommended supplier

Reine Lifescience

1Y Gujarat India
  • Since:2021-02-01
  • Address: Plot No.5901, Kanoria Chemicals Road, GIDC Estate, Dist. Bharuch, Ankleshwar, Gujarat-393 002, India
INQUIRY